Category Archives: Disability

China’s BeiGene gets nod from FDA for lymphoma med; significance extends further than just a win for one Chinese biotech.

The News: The US Food and Drug Administration has given the green light to market a blood cancer drug from Beijing-based BeiGene Ltd., paving the way for American patients to access a Chinese… Read more »

FDA panel unanimously backs use of Amarin’s fish-oil heart drug; action could produce gigantic profit haul.

The News: Government health experts recently recommended broader use of a prescription-strength fish oil drug to help many more patients at risk for heart attack, stroke and related health problems…. Read more »

Hillary not cool with Elizabeth Warren’s “Medicare for All;” neither are many docs.

The News: Hillary Clinton, the 2016 Democratic nominee, said last Wednesday she hoped for a return to “boring, normal times” after the 2020 election, voicing skepticism of her party’s populist… Read more »

Op-ed piece on “Quantity- versus quality-of-life for stage IV cancer patients: What my younger brother learned first-hand and later taught me.”

The News: A new, provocative study published in March in the journal Cancer sheds some light on the relationship between patients’ belief about their likely curability and the trade-offs they are prepared… Read more »

Middle-age hearing loss linked to dementia. Say again?

The News: Hearing loss in middle age is associated with higher odds of cognitive decline and dementia in later years, suggests a large study in Taiwan. Researchers tracked more than… Read more »

Tissue engineering and regenerative medicine starting to elbow its way into media coverage; watch out you cancer “miracle cures.”

The News: A group of researchers in Spain has developed a silk biomaterial that can increase the survival of transplanted stem cells into the brain, improving recovery after a stroke… Read more »

Forget about Biogen/Eisai’s promising new drug for Alzheimer’s; Study says aggressive blood-pressure treatment with existing meds reduces dementia/AD risk.

The News: After decades of prominent failures, hope arose for a drug to slow the progression of Alzheimer’s disease (AD). After heightening expectations recently, Eisai Co. Ltd. (Tokyo) and Biogen… Read more »